Assignment
Physicians can refer patients to the center for cell or gene therapy. An interdisciplinary indication board determines whether a patient is eligible.
Your Contacts in Hematology and Oncology
1. CAR-T Cell Therapy
Prof. Dr. Marion Subklewe and Dr. Veit Bücklein, Department of Medicine III. Please direct any inquiries regarding patient referrals to the center’s contact information on this page.
2. Gene Therapy for Beta-Thalassemia and Sickle Cell Disease
Specialized Outpatient Clinic for Hemoglobinopathies at the Department of Medicine III, Medical Director: Dr. Laura Distelmaier. Consultations take place at the Downtown Campus; appointments can be made through the office at +49 89 4400-34851.
For treatment outside the fields of hematology and oncology, the center works closely with the following colleagues in patient care:
1. Rheumatology
Prof. Dr. Hendrik Schulze-Koops, Division of Rheumatology and Clinical Immunology, Department of Medicine IV
2. Neuroimmunology
Prof. Dr. Tania Kümpfel, Institute of Clinical Neuroimmunology
3. Dermatology
Prof. Dr. Lucie Heinzerling, Department of Dermatology and Allergy
Early Clinical Trials: ECTU Tumor Board
If a patient with cancer is a potential candidate for an early-phase clinical trial, the treating physicians can have the patient’s eligibility reviewed by the ECTU Tumor Board. This also applies to colleagues in private practice. Applications are submitted via the ECTUnite online platform; after a one-time registration, this can be done at any time without a fixed meeting date. The Early Clinical Trial Units review the applications weekly and provide feedback on whether a suitable trial is available. The Tumor Board has been in operation since 2021 and operates at all six Bavarian ECTU sites of the Bavarian Center for Cancer Research. At LMU Medical Center, Dr. Veit Bücklein heads the Early Clinical Trial Unit at the Department of Medicine III.
General Inquiries
Munich Center for Cell and Gene Therapy
Director: Prof. Dr. med. Marion Subklewe
Administrative Assistant: Stefanie Grießhammer
